Diebold Nixdorf (DBD) Misses Q1 EPS by 13c; Reaffirms Outlook
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $67.08 -2.32%
Financial Fact:
Interest expense: -24.3M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Interest expense: -24.3M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q1 EPS of ($0.12), $0.13 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.08 billion.
- Reaffirms 2018 non-GAAP outlook
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Loop Capital Starts Dave Inc (DAVE) at Buy
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
